Combined 5-year trajectories of remnant cholesterol and HbA1c-derived estimated TyG index on risk of CVD and heart failure among New Zealanders with T2D
Aim People with type 2 diabetes (T2D) are at high risk of cardiovascular disease (CVD) and heart failure (HF). We assessed whether trajectories of remnant cholesterol (RC) and the HbA1c-derived estimated triglyceride–glucose index (estimated TyG index), individually and jointly, were associated with incident CVD and HF. Methods We conducted a cohort study of 43,505 with T2D in New Zealand (1994–2018), linked to hospital, death and socioeconomic data. Latent class growth analysis identified 5-year trajectories of RC and estimated TyG index. I Myocardial infarction, stroke, ischaemic heart disease and HF were ascertained from hospital and death records. Cause-specific Cox models, accounting for competing risk of death and adjusting for demographic, clinical, treatment and socioeconomic factors, estimated hazard ratios (HRs) for these outcomes across trajectory groups and combined trajectory groups. Results Four estimated TyG and three RC trajectories were identified. Compared with the lowest RC trajectory, intermediate and high trajectories were associated with higher risk of myocardial infarction (HR 1.71, 95% CI 1.57–1.86; and 2.24,1.96–2.56) and HF (1.64,1.51–1.77; and 2.24,1.97–2.54), with similar patterns for stroke and ischaemic heart disease. Higher estimated TyG trajectories showed smaller elevations, mainly in the highest group. Joint-trajectory analyses showed that groups with high RC and high estimated TyG index had the greatest risk. Conclusions In people with T2D, RC trajectories – particularly when combined with high estimated TyG index – are associated with CVD and HF. Monitoring these markers may provide complementary information for refining cardiovascular risk stratification and targeted prevention.
Authors
- Dahai Yu (ORCID: https://orcid.org/0000-0002-8449-7725)
- Richard G. Cutfield (ORCID: https://orcid.org/0000-0002-4171-059X)
- Bingjie Qu
- David S Simmons (ORCID: https://orcid.org/0000-0003-0560-0761)
- Brandon Orr‐Walker (ORCID: https://orcid.org/0009-0008-1079-2079)
- Yifan Shan (ORCID: https://orcid.org/0000-0002-6230-4312)
- Gerhard Sundborn (ORCID: https://orcid.org/0000-0001-7550-9096)
- JOHN BAKER (ORCID: https://orcid.org/0000-0002-4307-6748)
- Karen Pickering (ORCID: https://orcid.org/0009-0004-0322-6483)
- Yamei Cai
Institutions
- Camden and Campbelltown Hospitals (AU)
- Translational Research Institute (AU)
- University of Auckland (NZ)
- Zhengzhou University (CN)
- Pacific Radiology (New Zealand) (NZ)
- Waitemata District Health Board (NZ)
- Counties Manukau District Health Board (NZ)
- Arthritis UK (GB)
- Diabetes Foundation (IN)
- First Affiliated Hospital of Zhengzhou University (CN)
- Keele University (GB)
- Western Sydney University (AU)
Publication Details
- Journal
- European Heart Journal Open
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1093/ehjopen/oeag209
- Primary Topic
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Type
- article
- Field-Weighted Citation Impact
- 0.00